TARDBP and Alzheimer disease: The remaining 11 neuropathologically-confirmed AD cases were positive not only for anti-pTDP43409/410 or anti-pTDP43409, but also for anti-pTDP-43403/404 and antibodies raised against non-phosphorylated TDP-43 species, such as C-t TDP-43 and N-t TDP-43.